AllegisNL Capital Invests in Digital Health Company – Carrot Inc.

REDWOOD CITY, Calif., July 8, 2020 /PRNewswire/ — Digital health company Carrot Inc. today announced that AllegisNL Capital invested in its latest round of financing to accelerate commercialization of its Pivot tobacco cessation program. AllegisNL is backed by one of the largest life insurance companies globally. Carrot is AllegisNL’s first investment from its newest fund, focused on globally disruptive companies driving innovation in financial infrastructure, insurance, and digital health. AllegisNL joins Carrot’s current investor group – Khosla Ventures, Johnson and Johnson Development Corporation, New York Life Ventures, Marc Benioff, Valor Equity Partners, R7 Partners and Carrot founder David Utley.

Tobacco use is the leading cause of preventable illness and death worldwide. It kills 480,000 people in the U.S. each year and more than seven million globally. The lifespan of a tobacco user is 12 years shorter than that of a person who does not use tobacco. During the COVID-19 pandemic, tobacco users are at higher risk of contracting the virus and have higher rates of complications including death.

“Providing an evidence-based preventive service like tobacco cessation at scale is imperative for improving public health,” said David S. Utley, MD, Carrot founder and former Stanford head and neck cancer surgeon. “We are delighted that AllegisNL joins our other life insurance company backed investor, New York Life Ventures, in supporting Carrot.  There is a clear strategic benefit for life insurers to help their customers live longer healthier lives without tobacco. In clinical trials, Pivot demonstrated a 32% quit rate.”

Pivot is an evidence-based, mobile, tobacco cessation program that includes an FDA-cleared personalized carbon monoxide breath sensor (enables user to visualize their smoking behavior), a mobile app for motivation and skill building, personal coaching, free nicotine replacement medications, community support, lessons and challenges, and a clear path to helping users quit (cigarettes, e-cigarettes, smokeless tobacco).

“Using technology backed by science and proven with clinical trial outcomes to help people quit tobacco and live longer happier lives is an important benefit to society globally,” said Victor Westerlind, Managing Director at AllegisNL Capital. “Carrot has an extremely accomplished team that can bring this to market at scale and we are excited to join them on this opportunity.”

About Carrot Inc.
Carrot is a digital health company that delivers clinically proven, behavioral science-based solutions that empower people to take control of their personal health. Carrot’s first product is Pivot, a program designed to help people quit tobacco on their terms. In the future, Carrot will deliver additional products and services that address other chronic conditions such as alcohol and drug addiction, weight loss and exercise, digestive health, and diabetes prevention and management. To learn more, visit carrot.co.

About Pivot
Pivot is an evidence-based, mobile, tobacco cessation program that includes an FDA-cleared personalized carbon monoxide breath sensor (enables user to visualize their smoking behavior), a mobile app for motivation and skill building, personal coaching, free nicotine replacement medications, community support, lessons and challenges, and a clear path to helping users quit (cigarettes, e-cigarettes, smokeless tobacco). To learn more, visit pivot.co.

About AllegisNL Capital
Backed by one of the largest life insurance companies in the world, AllegisNL is part of the Allegis Capital family of venture capital funds based in Palo Alto, CA and invests in innovative companies at the intersection of technology, finance, insurance and digital health.

View original content to download multimedia:http://www.prnewswire.com/news-releases/allegisnl-capital-invests-in-digital-health-company—carrot-inc-301090466.html

SOURCE Carrot Inc.

Staff

Recent Posts

The State of HTM, 2025: Report Signals Changing Health Tech Workforce

Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…

45 minutes ago

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…

2 hours ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth…

2 hours ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…

2 hours ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…

2 hours ago

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as…

2 hours ago